Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Mayo Clinic
University of Giessen
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Minnesota